16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment

Bibliographic Details
Main Authors: Christopher Maher, Jin Zhang, Hemanth Potluri, Tun Lee Ng, Michael Newton, Peter Nelson, Douglas McNeel
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-795075d36a0c4b0cb9d4db126b9a8f39
record_format Article
spelling doaj-795075d36a0c4b0cb9d4db126b9a8f392020-12-11T10:00:25ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.001616 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatmentChristopher Maher0Jin Zhang1Hemanth Potluri2Tun Lee Ng3Michael Newton4Peter Nelson5Douglas McNeel62Washington University in St. Louis, St. Louis, MO, USA2Washington University in St. Louis, St. Louis, MO, USA1UW-Madison, Madison, WI, USA1UW-Madison, Madison, WI, USA1UW-Madison, Madison, WI, USA3Fred Hutchinson Cancer Research Center, Seattle, WA, USA1UW-Madison, Madison, WI, USA
collection DOAJ
language English
format Article
sources DOAJ
author Christopher Maher
Jin Zhang
Hemanth Potluri
Tun Lee Ng
Michael Newton
Peter Nelson
Douglas McNeel
spellingShingle Christopher Maher
Jin Zhang
Hemanth Potluri
Tun Lee Ng
Michael Newton
Peter Nelson
Douglas McNeel
16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
Journal for ImmunoTherapy of Cancer
author_facet Christopher Maher
Jin Zhang
Hemanth Potluri
Tun Lee Ng
Michael Newton
Peter Nelson
Douglas McNeel
author_sort Christopher Maher
title 16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
title_short 16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
title_full 16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
title_fullStr 16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
title_full_unstemmed 16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
title_sort 16 antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT christophermaher 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
AT jinzhang 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
AT hemanthpotluri 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
AT tunleeng 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
AT michaelnewton 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
AT peternelson 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
AT douglasmcneel 16antibodyprofilingofprostatecancerpatientsrevealsdifferencesinantibodysignaturesamongdiseasestagesandfollowingtreatment
_version_ 1724386678659874816